organization · Reporting owner
Tru St Partnership, L.P.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | 10% owner | December 16, 2021 | March 25, 2022 |
| SeaSpine Holdings CorpSPNE · Entity 120832 | 10% owner | February 10, 2021 | February 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date December 16, 2021 · Filed March 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,515,930 |
Ending reported balance
After 2022-03-23 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-12-16 · Sale · Disposed 75,000 · Balance 8,740,930 F1: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.28 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. Row 2 · 2022-02-09 · Sale · Disposed 75,000 · Balance 8,665,930 F2: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $65.82 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. Row 3 · 2022-03-23 · Sale · Disposed 150,000 · Balance 8,515,930 F3: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.67 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.28 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
F2: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $65.82 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
F3: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.67 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
SeaSpine Holdings Corp
Report date February 10, 2021 · Filed February 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,997,068 |
Reported balance
Holding disclosure · report date 2021-02-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,997,068 F1: These securities were previously reported as indirectly owned by Dr. Richard Caruso. As of the date of this filing, Dr. Caruso may no longer be deemed to be the beneficial owner of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were previously reported as indirectly owned by Dr. Richard Caruso. As of the date of this filing, Dr. Caruso may no longer be deemed to be the beneficial owner of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2022 Filed Mar 25, 2022 21:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 150,000 | $64.67 | $9,700,500.00 |
DisclosureSEC source: 0000899243-22-012345 · doc4.xml · nonDerivative · entry 3 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,515,930 F3 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.67 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| February 09, 2022 Filed Mar 25, 2022 21:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 75,000 | $65.82 | $4,936,500.00 |
DisclosureSEC source: 0000899243-22-012345 · doc4.xml · nonDerivative · entry 2 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,665,930 F2 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $65.82 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| December 16, 2021 Filed Mar 25, 2022 21:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 75,000 | $64.28 | $4,821,000.00 |
DisclosureSEC source: 0000899243-22-012345 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,740,930 F1 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.28 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 18:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 75,000 | $68.59 | $5,144,250.00 |
DisclosureSEC source: 0000899243-21-045361 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,815,930 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $68.59 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. Read SEC document |
| October 20, 2021 Filed Oct 27, 2021 18:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 200,000 | $69.81 | $13,962,000.00 |
DisclosureSEC source: 0000899243-21-041695 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,890,930 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $69.81 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. Late filing due to administrative error. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 730,000 | $68.14 | $49,742,200.00 |
DisclosureSEC source: 0001209191-21-022332 · doc4.xml · nonDerivative · entry 2 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,090,930 F2 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $68.14 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. F2 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $68.14 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| February 18, 2021 Filed Mar 22, 2021 20:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 70,275 | $71.15 | $5,000,066.25 |
DisclosureSEC source: 0001209191-21-022332 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,820,930 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $71.15 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Late filing due to administrative error. F1 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $71.15 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Late filing due to administrative error. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:09 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 200,000 | $60.77 | $12,154,000.00 |
DisclosureSEC source: 0001209191-20-064623 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,891,205 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $60.77 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. F1 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $60.77 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 200,000 | $46.97 | $9,394,000.00 |
DisclosureSEC source: 0001209191-20-051288 · doc4.xml · nonDerivative · entry 1 Tru St Partnership, L.P. · CIK 0001824663 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,091,205 F1 · shares: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $46.97 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. F1 · price: The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $46.97 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.